Search

Search Results

1. Botulinum Toxin Treatment in Multiple Sclerosis

   According to the latest data from the National Multiple Sclerosis Society (2019) nearly one million people live in US with this disease annually. The...

   Bahman Jabbari in Botulinum Toxin Treatment

   Chapter 2024
   

2. Causal relationship between multiple sclerosis and cortical structure: a Mendelian randomization study

   Background

   Observational studies have suggested an association between multiple sclerosis (MS) and cortical structure, but the results have been...

   Dongren Sun, Rui Wang, ... Hongyu Zhou in Journal of Translational Medicine

   Article Open access 20 January 2024
   

3. Ataxia in Multiple Sclerosis

   It is well known that the cerebellum is commonly affected in patients with multiple sclerosis (MS), thus making everyday life activities such as...

   Giacomo Koch, Danny Adrian Spampinato in Essentials of Cerebellum and Cerebellar Disorders

   Chapter 2023
   

4. Multiple Sclerosis

   Almost 200 years since it was first described, multiple sclerosis (MS) remains one of the most intriguing human diseases, with a complexity of...

   Samuel K. Ludwin, Jack Antel, Douglas L. Arnold in Neuroscience in the 21st Century

   Reference work entry 2022
   

5. Active Induction of a Multiple Sclerosis-Like Disease in Common Laboratory Mouse Strains

   Experimental autoimmune encephalomyelitis (EAE) is a neuroinflammatory disease with facets in common with multiple sclerosis (MS). It is induced in...

   Jacqueline M. Orian, Dain L. Maxwell, Vernise J. T. Lim in Neurobiology

   Protocol 2024
   

6. Interhemispheric inhibition and gait adaptation associations in people with multiple sclerosis

   Background

   Multiple sclerosis is a neurodegenerative disease that damages the myelin sheath within the central nervous system. Axonal demyelination,...

   Andrew C. Hagen, Jordan S. Acosta, ... Brett W. Fling in Experimental Brain Research

   Article 01 June 2024
   

7. Sleep Disorders in Multiple Sclerosis

   Multiple sclerosis (MS) is the most common chronic inflammatory demyelinating disease of the central nervous system. Along with a variety of motor...

   Govind Madhaw, Niraj Kumar in Sleep and Neuropsychiatric Disorders

   Chapter 2022
   

8. Neuropathic Pain in Multiple Sclerosis Patients

   Among a multitude of pain syndromes (PS) of diverse locations and types of pathogenesis encountered in multiple sclerosis (MS) patients, most...

   N. N. Spirin, D. V. Kiselev, M. S. Karpova in Neuroscience and Behavioral Physiology

   Article 01 May 2022

9. Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis

   The purinergic signaling system comprises a complex network of extracellular purines and purine-metabolizing ectoenzymes, nucleotide and nucleoside...

   Danijela Laketa, Irena Lavrnja in Molecular Neurobiology

   Article 18 March 2024
   

10. Evidence for the differential efficacy of yaw and pitch gaze stabilization mechanisms in people with multiple sclerosis

    People with multiple sclerosis (PwMS) who report dizziness often have gaze instability due to vestibulo-ocular reflex (VOR) deficiencies and...

    Colin R. Grove, Brian J. Loyd, ... Michael C. Schubert in Experimental Brain Research

    Article 05 June 2024
    

11. Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis

    Multiple sclerosis (MS) is a neurodegenerative and autoimmune disease affecting the central nervous system (CNS). The precise etiology of MS is still...

    Chiara Suvieri, Claudia Volpi in Toll-Like Receptors

    Protocol 2023
    

12. Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis

    Thalamic volume is associated with clinical disability in multiple sclerosis (MS) and is vulnerable to secondary neurodegeneration due to its...

    Gabrielle M. Mey, Kirsten S. Evonuk, ... Tara M. DeSilva in Acta Neuropathologica Communications

    Article Open access 15 June 2022
    

13. Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis

    Background

    Multiple sclerosis (MS) is a progressive neurodegenerative disease of the central nervous system characterized by inflammation-driven...

    Livia Guadalupi, Valentina Vanni, ... Alessandra Musella in Journal of Neuroinflammation

    Article Open access 14 May 2024
    

14. Quantitative Meta-analyses of Cognitive Abilities in Children With Pediatric-onset Multiple Sclerosis

    Pediatric-onset multiple sclerosis (POMS), is the manifestation of multiple sclerosis in individuals before 18 years of age. About a third of...

    Elena S. Lysenko, Mariia D. Bogdanova, Marie Arsalidou in Neuropsychology Review

    Article 08 July 2022
    

15. Frontal-striatal glucose metabolism and fatigue in patients with multiple sclerosis, long COVID, and COVID-19 recovered controls

    This study compared brain glucose metabolism using FDG-PET in the caudate nucleus, putamen, globus pallidus, thalamus, and dorsolateral prefrontal...

    Thorsten Rudroff in Experimental Brain Research

    Article 06 July 2024
    

16. Effects of the powerball® system on muscle strength, coordination, fatigue, functionality and quality of life in people with multiple sclerosis. A randomized clinical trial

    Introduction

    Although clinical and functional impairments in the lower limbs have been extensively studied in patients with MS, the upper limb (UL)...

    Aitor Blázquez-Fernández, Gemma López-Hazas-Jiménez, ... Roberto Cano-de-la-Cuerda in Journal of NeuroEngineering and Rehabilitation

    Article Open access 02 March 2024
    

17. Visual oscillation effects on dynamic balance control in people with multiple sclerosis

    Background

    People with multiple sclerosis (PwMS) have balance deficits while ambulating through environments that contain moving objects or visual...

    Lara Riem, Scott A. Beardsley, ... Brian D. Schmit in Journal of NeuroEngineering and Rehabilitation

    Article Open access 17 August 2022
    

18. Drug Delivery Strategies in Multiple Sclerosis, Huntington’s Disease and Other Neurodegenerative Diseases

    In healthy individuals, the blood–brain barrier (BBB) protects the brain by obstructing tiny harmful substances in the blood only by hindering the...

    Sofiya Tarannum, Keerti Jain in Drug Delivery Strategies in Neurological Disorders: Challenges and Opportunities

    Chapter 2023
    

19. Conversion of Astrocyte Cell Lines to Oligodendrocyte Progenitor Cells Using Small Molecules and Transplantation to Animal Model of Multiple Sclerosis

    Astrocytes, the most prevalent cells in the central nervous system (CNS), can be transformed into neurons and oligodendrocyte progenitor cells (OPCs)...

    Mohsen Sharifi-Kelishadi, Leila Zare, ... Mohammad Javan in Journal of Molecular Neuroscience

    Article 09 April 2024
    

20. An Update on the Measurement of Motor Cerebellar Dysfunction in Multiple Sclerosis

    Multiple sclerosis (MS) is a progressive disease that often affects the cerebellum. It is characterised by demyelination, inflammation, and...

    Katherine Hope Kenyon, Frederique Boonstra, ... Anneke van der Walt in The Cerebellum

    Article Open access 27 June 2022